IL17A and depressive symptom measurement: Multiple comparisons showed that neutralization of IL‐17A treatment could significantly alleviate depression levels (p < 0.01 or 0.001), and the performances of IMQ plus neutralization of IL‐17A group were similar to the control group (all p > 0.05).